HPNOW LTD

Their core work

HPNOW LTD is an Israeli technology SME whose core business is on-site hydrogen peroxide (H2O2) generation — systems that produce H2O2 directly at the point of use, removing the need to transport or store concentrated chemical oxidants. Their technology has demonstrated applications in agricultural water treatment (irrigation disinfection) and in broader industrial settings where affordable, safe H2O2 supply is a bottleneck. In EU projects they appear as a third-party technology provider, meaning their proprietary generation system is embedded into another organization's project as a supplied component or licensed technology. The consistency of both projects around the same core chemistry suggests this is their primary commercial product, not a research side-line.

What they specialise in

How they've shifted over time

Both projects center on the same core technology — on-site hydrogen peroxide generation — but show a deliberate shift in application scope. The earlier HPGen project (2017–2019) was tightly focused on agricultural water treatment, specifically irrigation disinfection, which is a well-defined niche market. PeroxyPro (2020–2022) dropped the agricultural framing entirely and addressed on-site H2O2 generation as a general-purpose platform, emphasizing affordability and security of supply. This trajectory suggests the company moved from validating the technology in a single vertical toward positioning it as a horizontal capability applicable across food, water, and industrial sectors.

HPNOW is moving from a niche agricultural application toward a platform technology positioned for multiple end markets — food processing, industrial sanitation, and water utilities — which broadens their potential consortium value but may diffuse their commercial focus.

How they like to work

HPNOW appears exclusively as a third party in EU projects — not as a formal partner or coordinator — which means another organization (likely a customer or co-developer) brings them into consortia as a technology supplier. With only one unique consortium partner across two projects, they appear to have a close, possibly exclusive working relationship with a single EU company that acts as the front-facing project proponent. This profile is consistent with a deep technology provider model: one product, one main channel partner, validated twice in succession.

HPNOW's traceable EU collaboration network is extremely narrow: one unique partner in one country across both projects. This is not a research network — it is a supplier relationship embedded in another SME's project portfolio.

What sets them apart

HPNOW appears to hold proprietary technology for decentralized, on-site hydrogen peroxide generation — a genuinely niche capability that is commercially valuable in sectors where safe oxidant supply is a recurring cost or logistics problem (agriculture, food processing, municipal water treatment). Unlike research labs that study H2O2 chemistry, HPNOW seemingly produces deployable systems, which makes them a technology provider rather than a knowledge provider. For a consortium that needs a proven H2O2 generation component rather than yet another research partner, HPNOW is a rare specialist.

Highlights from their portfolio

• HPGen
  The founding application of HPNOW's technology in EU research, demonstrating viable on-site H2O2 generation for irrigation — a commercially underserved niche at the intersection of agriculture and water chemistry.
• PeroxyPro
  Marks the pivot from single-vertical (agriculture) to a platform product pitch, signaling a deliberate market-expansion strategy and indicating the technology reached sufficient maturity to generalize.